Silence Therapeutics (SLN) Q3 2025 Earnings

Aug 7Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.09
-0.05
-0.01
0.02

Details

Expected EPS
-0.04482192
Actual EPS
-0.0648689184
Surprise EPS
-0.02
Surprise Percent
-44.73%

Description

⁨Silence Therapeutics⁩ (⁦SLN⁩) has reported earnings of ⁦-0.0648689184⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts